Ion Beam Applications S.A.
BRU: IBAB.BR0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Euronext Brussels
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Olivier Legrain
- Employees
- 2,118
- Headquarters
- Louvain-la-Neuve, Belgium
- IPO year
- 2000
- Market cap
- €439.6M
- Website
- https://www.iba-worldwide.com
Loading IBAB…
Loading profile data…Frequently asked questions about IBAB
What does Ion Beam Applications S.A. (IBAB.BR) do?
Ion Beam Applications SA develops, manufactures, and supports medical devices and software solutions for cancer treatments in Belgium, the United States, and internationally. The company operates through Proton Therapy and Other Accelerators, and Dosimetry segments. The Proton Therapy and Other Accelerators segment develops, fabricates, and serv...
Where does IBAB.BR trade?
Ion Beam Applications S.A. (IBAB.BR) trades on the Euronext Brussels.
What sector is IBAB.BR in?
Ion Beam Applications S.A. (IBAB.BR) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Ion Beam Applications S.A.?
Olivier Legrain is the chief executive officer of Ion Beam Applications S.A. (IBAB.BR).
Where is Ion Beam Applications S.A. headquartered?
Ion Beam Applications S.A. is headquartered in Belgium.
Does IBAB.BR pay a dividend?
Yes — Ion Beam Applications S.A. (IBAB.BR) paid a trailing twelve-month dividend of EUR 0.24 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did IBAB.BR go public?
Ion Beam Applications S.A. (IBAB.BR) completed its initial public offering in 2000.